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Abstract
The development of tissue engineered osteochondral units has been slowed by a number of technical hurdles
associated with recapitulating their heterogeneous nature ex vivo. Subsequently, numerous approaches with respect to cell sourcing, scaffolding composition, and culture media formulation have been pursued, which have
led to high variability in outcomes and ultimately the lack of a consensus bioprocessing strategy. As such, the
objective of this study was to standardize the design process by focusing on differentially supporting formation
of cartilaginous and bony matrix by a single cell source in a spatially controlled manner within a single material
system. A cell-polymer solution of bovine mesenchymal stem cells and agarose was cast against micromolds of a
serpentine network and stacked to produce tissue constructs containing two independent microﬂuidic networks. Constructs were ﬂuidically connected to two controlled ﬂow loops and supplied with independently
tuned differentiation parameters for chondrogenic and osteogenic induction, respectively. Constructs receiving
inductive media showed differential gene expression of both chondrogenic and osteogenic markers in opposite
directions along the thickness of the construct that was recapitulated at the protein level with respect to collagens I, II, and X. A control group receiving noninductive media showed homogeneous expression of these biomarkers measured in lower concentrations at both the mRNA and protein level. This work represents an
important step in the rational design of engineered osteochondral units through establishment of an enabling
technology for further optimization of scaffolding formulations and bioprocessing conditions toward the production of commercially viable osteochondral tissue products.
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Introduction
The development of engineered tissue grafts has
emerged as a promising therapeutic alternative for
the repair and replacement of organs. A number of approaches, using a diverse spectrum of scaffolds, cell
populations, and bioprocessing conditions, have been
pursued for the production of such grafts. A plurality
of these efforts has been centered around the development of homogenous tissues intended to mimic the

functional properties of the target tissue in vivo.
Some tissues, however, are heterogeneous both structurally and functionally and possess spatially varying
biochemical compositions and mechanical properties
for which the use of a single scaffolding material,
cell source, or bioreactor chamber may be inappropriate. A classic example of this is the osteochondral
unit, consisting of a hyaline cartilage layer and the
integrated subchondral bone.
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Osteochondral defects, resulting from traumatic injury, are typically treated through a grafting technique
termed mosaicplasty.2 One of the primary shortcomings
of mosaicplasty is the reliance on autologous graft sourcing from a healthy nonload bearing site that is both limited in its availability and potentially inappropriate for
repair due to advanced osteoarthritic degeneration.1,2
To address this supply issue, a number of approaches
have been pursued to create a suitable replacement for
the autologous grafts. Common approaches to recapitulate the unique heterogeneity of the osteochondral
unit include the production of composite scaffoldings
loaded with one or more cell sources having chondrogenic and/or osteogenic potential and cultivating them
utilizing both commercially available and custom-built
bioreactor systems.3 Constructs produced in this manner, however, are still nonoptimal as they suffer from a
number of shortcomings. Arguably, the most pertinent
shortcoming of these approaches is their reliance on
terminally differentiated cells (osteoblasts and chondrocytes) isolated from patient-speciﬁc biopsies and
expanded in vitro. Use of terminally differentiated
cells is plagued by the same dependency on an available
autologous donor site, as well as low proliferation rates
and potential degradation of functionality, should
in vitro expansion be necessary to sufﬁciently populate
the tissue engineered construct.4
Mitigation of this particular shortcoming can be accomplished by utilizing undifferentiated multipotent
mesenchymal stem cells (MSCs) as a single autologous
cell source for repair of osteochondral defects.3,5–8
MSCs are well-known progenitor cells for both the
chondrocyte and osteoblast lineages, which have been
used to generate osteochondral constructs using singlecomponent or composite scaffolds across a range of
compositions and material properties.3,6,9–19 The primary challenge to MSC-based constructs arises from
the need to either utilize costly predifferentiation operations before the seeding of the construct or simultaneously
modulate differentiation down to distinct lineages in a
uniﬁed culture solution. Using conventional bioreactor
systems, the popular approach of supplementing the culture media with lineage-speciﬁc signaling molecules to
achieve directed differentiation of MSC is untenable for
biphasic constructs without some means of spatially directed delivery to prevent dominance of one desired phenotype throughout the construct.20
Based on these realities, we hypothesized that the
spatially conﬁned presentation of optimized differentiation cues would result in tissue-speciﬁc inductive re-
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gions for the regeneration of both bone and cartilage
tissues using a model universal donor cell source in an
integrated tissue construct. To test this hypothesis, we utilized a microﬂuidic hydrogel platform previously developed in our laboratory to stimulate region-speciﬁc
induction of osteoblastic and chondrogenic phenotypes
through parallel, independent microﬂuidic networks and
evaluated the constructs after 2 weeks of culture for the
presence of differential gene expression and matrix composition between the osteogenic and chondrogenic layers.
Materials and Methods
Supplies and reagents were obtained from VWR International, Sigma, or Invitrogen unless otherwise speciﬁed.
Antibodies were from AbD Serotec or Abcam. ELISA
kits for Collagens I and II were purchased from Chondrex, Inc. and for Collagen X from MyBioSource, Inc.
MSC isolation and characterization
Bone marrow aspirates from bovine calves (Research
87) were mixed with expansion medium (high-glucose
Dulbecco’s modiﬁed Eagle’s medium [DMEM] supplemented with 10% certiﬁed fetal bovine serum [FBS]
and 1· penicillin–streptomycin–fungizone [PSF]) supplemented with 300 U/mL heparin and subjected to
straining and centrifugation processes. Following centrifugation, pelleted cells were suspended in fresh expansion medium and plated onto T-75 ﬂasks (Corning,
Inc.). Nonadherent cells were removed from the ﬂasks
after 24 h, while adherent cells were cultured to conﬂuence. Subsequent subculturing was carried out to Passage 3 at a splitting ratio of 1:3. Following Passage 3,
MSCs were placed in a cryoprotective medium (70%
DMEM, 20% FBS, 10% dimethyl sulfoxide [DMSO])
at a concentration of 1 million cells/mL stored in liquid
nitrogen in 1 mL aliquots.
Tissue culture
Constructs were fabricated by casting a cell-polymer solution (25 million MSC/mL; 2.5% agarose) against
plasma-treated PDMS molds of the microﬂuidic network
as described previously.21 Independent networks were
formed by sealing a planar slab of the cell-polymer solution between the molded portions in an acrylic casing
(Fig. 1). External ﬂow loops were connected through
luer-lock interfaces on the acrylic casing. Unidirectional
ﬂow of culture media was achieved using a syringe pump
equipped with dual check valves. Capitalizing on the independence of the ﬂuidic networks, culture commenced
under regionally speciﬁc bioprocessing conditions.
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FIG. 1. Construction process of the microﬂuidic osteochondral graft. Each target region is independently cast
and controlled through ports in the acrylic casing. The chondrogenic and osteogenic regions are separated by
a planar midsubstance region molded directly into a PDMS gasket, which ensures unidirectional ﬂow through
the microﬂuidic networks.

Constructs from the experimental group received two
different sets of bioprocessing conditions. The osteogenic
region was provided with a serum-free basal media (highglucose DMEM, 1· PSF, 0.1 lM dexamethasone, 50 lg/
mL ascorbate 2-phosphate, 40 lg/mL L-proline, 100 lg/
mL sodium pyruvate, 1· insulin–transferrin–selenium)
supplemented with 10 ng/mL BMP-2 at a constant perfusion rate of 2.5 mL/min such that the shear stress distribution at the microchannel walls was a uniform 10
dyne/cm2. The chondrogenic region was supplied with
serum-free basal media supplemented with 100 ng/mL
TGF-b3 at 250 lL/min. The ﬂow rate for the chondrogenic region was determined to both fulﬁll the minimal
ﬂow rate requirements for the nutrient demands of the
resident cell population21 and to provide a uniform,
low-magnitude shear stress distribution of 1 dyne/cm2
at the microchannel walls. For the control group, both
microﬂuidic networks of the tissue constructs were provided with noninductive serum-free basal media at a
ﬂow rate of 250 lL/min ﬂow rate. Total culture media
volume was maintained at 100 mL with fresh media

exchanges performed every 3–4 days. Gas exchange
and pH balance were maintained by bubbling a 5%
CO2 balance air gas mixture through the culture
media reservoir.
mRNA expression
Quantitative reverse transcription polymerase chain
reaction (RT-qPCR) was used to quantify gene expression within the constructs in a region speciﬁc manner.
RNA was isolated from the homogenized cell lysate
according to the TRIzol protocol. Reverse transcription of the RNA into cDNA was achieved using a
QuantiTect Rev Transcription Kit (QIAGEN). RealTime PCR ampliﬁcation was performed (StepOnePlus; Applied Biosystems) in the presence of SYBR
Green/ROX master mix and primers for target osteochondral lineage markers (Supplementary Table S1).
Regulation of the target genes over day 0 controls
was determined by processing the raw ﬂuorescence
data using LinRegPCR (v12.11; www.hartfaalcentrum
.nl) with glyceraldehyde-3-phosphate dehydrogenase
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(GAPDH) and b-actin (ACTB) serving as the endogenous controls through geometric averaging.22
Biochemical analyses
Construct weights (wet weight) were taken before freezing (80C) and subsequent lyophilization. Lyophilized
samples were weighed again (dry weight) and digested
in papain buffer for 16 h at 60C. Aliquots of digested
samples were assessed for DNA content using a PicoGreen dsDNA Kit. Glycosaminoglycan (GAG) content
was measured using the dimethylmethylene blue dyebinding assay.23 Quantiﬁcation of collagen types I, II,
and X was carried out using ELISA Kits as per manufacturers’ protocols.
Histological analyses
Tissue constructs were ﬁxed in 10% (v/v) neutralbuffered formalin, dehydrated through an ethanol gradient, embedded in parafﬁn wax, and cut into sections of
8.0 lm. Deparafﬁnized sections were then stained with
Toluidine Blue for proteoglycans and Alizarin Red for
calcium. For immunoﬂuorescence, samples were blocked
for 30 min and incubated with primary rabbit antibodies
(1:100) against collagen types I, II, and X at 4C overnight following antigen retrieval using the citrate buffer
method. Sections were then washed thrice in PBS
and treated with goat anti-rabbit secondary antibodies
(1:200) for 1 h at room temperature. Sections were
washed once more and mounted with VECTASHIELD
containing DAPI. Photomicrographs were captured
on an inverted ﬂuorescence microscope (Nikon Instruments, Inc.) equipped with a CCD camera (CoolSNAP
HQ2 CCD; Photometrics).
Statistical analysis
Sample sizes for RT-qPCR and biochemical analyses
were n = 3 and n = 5, respectively. Bar graphs are presented as the mean – SEM with statistically signiﬁcant
differences deﬁned as p < 0.05 using two-way ANOVA
with Bonferroni post hoc tests for multiple comparisons.
Results
Cellular content
As depicted in Figure 2, there was no signiﬁcant difference in DNA content between any of the spatially distinct regions within either the experimental or control
groups. There was, however, a statistically signiﬁcant
difference in DNA content between the control and experimental groups across all phenotypic regions of the
tissue constructs after 2 weeks of culture. This differ-

FIG. 2. After 2 weeks of culture, DNA content
was signiﬁcantly higher in the experimental group,
which received cytokine supplementation relative
to the unsupplemented control group. There were
no signiﬁcant differences between the various
regions of the experimental cultures. *Indicates a
statistically signiﬁcant ﬁnding (p < 0.05).

ence indicates increased cell proliferation within the
experimental group relative to the control group.
Differential expression of osteochondral genes
Within the control group, no difference was observed in the osteogenic (RUNX2, OSTEOCALCIN,
and COL1A1), hypertrophic (COLXA1), or chondrogenic (SOX9, AGGRECAN, and COL2A1) gene expression proﬁles between the various regions of the
tissue constructs. Within the experimental group,
however, differential expression of both the osteogenic
and chondrogenic gene expression proﬁles with respect
to the opposing construct region was observed (Fig. 3).
Within the osteogenic target region, a statistically signiﬁcant upregulation of RUNX2 (86-fold) and COL1A1
(29-fold) was observed relative to the chondrogenic target
region. Regulation of the osteogenic gene panel was also
greater compared with the chondrogenic panel with the
exception of aggrecan, but not in a statistically signiﬁcant
manner. With regard to the chondrogenic gene panel, a
statistically signiﬁcant regulation of the entire chondrogenic gene panel (SOX9, AGGRECAN, and COL2A1)
within the chondrogenic region was observed relative to
the osteogenic target region of the construct. In addition,
COLXA1 expression was observed to increase across the
construct from the chondrogenic regions to the osteogenic region, with a statistically signiﬁcant difference
in expression occurring between the chondrogenic and
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FIG. 3. Differential loading of an osteochondral tissue construct results in gene expression gradients of both
osteogenic and chondrogenic genes. *Indicates a statistically signiﬁcant ﬁnding (p < 0.05).

osteogenic regions, but not with such difference occurring
between the midsubstance and osteogenic regions.
GAG content
As evidenced by the results of the DMMB assay, GAG
content was signiﬁcantly higher in the experimental
group relative to the control group (Fig. 4). In addition,
within the experimental group, GAG content was on average highest in the chondrogenic target region and lowest
in the osteogenic region. The difference in average GAG
content in the chondrogenic and the osteogenic regions
of the experimental group, however, was not considered
statistically signiﬁcant. In addition, no statistically signiﬁcant difference in GAG content was observed between the
construct regions of the control groups.
Graded collagen expression
ELISA was performed for expression of collagens Type
I, II, and X. As depicted in Figure 5, all three collagen

types exhibited graded expression across the construct
thickness, with types I and X exhibiting their maximum
concentration in the osteogenic target region of the
construct and type II exhibiting a maximum concentration in the chondrogenic region of the construct.
Within the control group, collagen content was significantly lower with no gradations of note.
Histology and immunoﬂuorescence
Control constructs stained weakly and relatively homogeneously for both histological stains and for all
collagens tested following 2 weeks of culture (Fig. 6).
The experimental group, however, exhibited much
stronger staining across all regions. Within the experimental group, Toluidine Blue staining revealed no discernible difference in proteoglycan content between
the various regions of the osteochondral constructs. Alizarin Red staining revealed a slight gradient in mineralization with a region of high concentration within the
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FIG. 4. Measurement of sulfated
glycosaminoglycan content within the various
regions of the osteochondral constructs by
DMMB assay reveals signiﬁcantly higher GAG
accumulation in the experimental group
irrespective of the construct region relative to the
control group. Within the experimental group,
however, no statistically signiﬁcant differences
were observed. GAG, glycosaminoglycan.
*Indicates a statistically signiﬁcant ﬁnding (p < 0.05).

osteogenic layer and a region of low concentration in the
chondrogenic layer. Collagen staining revealed a mild
gradient in both type I and type II collagen with the
highest concentration of each located within the osteogenic and chondrogenic layers, respectively. Collagen
X staining results were inconclusive between regions
in the experimental group, but clearly higher relative
to the control group.
Discussion
The purpose of the study described herein was to evaluate microﬂuidic hydrogels as a platform for the production of osteochondral tissue constructs through the
spatially directed differentiation of bovine MSCs. The
ability of the mechanochemical inductive cues provided
through the microﬂuidic networks to direct targeted
phenotype induction was evaluated through gene expression analysis, biochemical composition, and histological staining. Relative to our noninductive control
cultures, the spatially deﬁned presentation of inductive
factors and bioprocessing conditions had a clear impact
in proliferation of the resident cell population and elaboration of a spatially discrete osteochondral matrix
within our experimental group. On a whole construct

FIG. 5. ELISA reveals gradients in Collagen type
I across the osteochondral constructs and
differential expression of collagen types II and X
between the osteogenic and chondrogenic
regions of the experimental group. *Indicates a
statistically signiﬁcant ﬁnding (p < 0.05).
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FIG. 6. Immunoﬂuorescence staining shows gradients in collagen types I and II. Alizarin red staining also
indicates increased mineralization within the osteogenic region relative to the chondrogenic region.

basis, differences between the control and experimental
constructs included signiﬁcant increases in both DNA
content and total osteochondral matrix elaboration.
These ﬁndings are in agreement with the prior literature on the effects of the TGF-b superfamily proteins
provided to these cultures,24,25 as well as to previous
ﬁndings from our group on the synergistic effects of hydrodynamic loading on MSC differentiation efﬁciency
in the presence of these factors.26 Within the experimental group, there was evidence of spatial differences in
matrix composition reminiscent of the osteochondral
junction. The chondrogenic target region of the construct showed a local maximum of GAG content and
signiﬁcantly higher expression of Collagen II relative
to the osteogenic target region, while signiﬁcantly higher
expression of Collagen I and X was observed in addition

to a minimum in GAG content in the osteogenically targeted region of the constructs. In addition, Alizarin Red
staining showed an increase in mineralization within
the osteogenic region. The dual presence of GAG and
mineralization within the osteogenic region indicates
the concurrent formation of both cartilage and bone,
and may represent an intermediate differentiation step
along the endochondral ossiﬁcation pathway for the culture period studied herein, rather than a terminal bone
phenotype. While suboptimal, we believe this result to
be acceptable for the culture durations studied and hypothesize that cultivation for longer durations would result in replacement of the cartilaginous portion of the
matrix with higher quality bone formation.25,27 This is
further supported by the relatively lower presence of
both Collagen I and mineralization in the chondrogenic
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region indicating that this endochondral bone formation
is concentrated near the BMP-2 supply network and
that the cartilage formation in the chondrogenic region
is hyaline in character.
In benchmarking our technology in the context of
other studies, we note that a number of studies have
been reported utilizing dual culture control systems for
osteochondral tissue engineering. Chang et al. cultured
a gelatin-infused sinbone block to generate osteochondral constructs in a dual-chambered bioreactor approach that validated their scaffolding system for the
production of hyaline cartilage within the gelatin portion of the composite scaffolding.28 The bony portion
of this scaffold, however, was acellular in nature. Mahmoudifar and Doran used a similar dual-chambered
bioreactor to that implemented by Chang et al. for the
production of osteochondral tissue constructs from
two sutured together polyglycolic acid meshes seeded
with adipose-derived stem cells.29 This approach mirrored our results after 2 weeks of culture with respect
to statistically indeterminate differences in GAG content
between the layers, but was not in agreement with our
ﬁnding of differential expression of collagen II. Compared to these studies, our constructs are not only cellularized in both the osteogenic and chondrogenic regions
as was also shown by Mahmoudifar and Doran but also
our system was shown to suppress osteogenic character
within the chondrogenic layer. While the characteristics
of the cell type seeded in each of these systems may also
play a role in the improvement shown with respect to
this metric, we believe the improvement is due to improved control of the microenvironment provided by
the presence of the microﬂuidic network within the tissue construct versus the superﬁcial delivery of inductive
cues characteristic of the dual-chambered bioreactor.
While more involved than the dual-chambered bioreactor, the paradigm proposed by our system offers the capability to produce thicker constructs as necessary and
even greater opportunities for optimization of culture
conditions through the incorporation of independent
microﬂuidic networks into the construct.
Conclusions
In this study, we have established a paradigm for the production of biphasic tissue constructs through microﬂuidically directed differentiation of MSCs using the
osteochondral unit as a model tissue. While there is evidence in the literature of other approaches to spatially
engineer the composition of an osteochondral construct,
this study is the ﬁrst of its kind to utilize microﬂuidic net-
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works to successfully engineer a biphasic tissue of clinically relevant thickness with measurable differences in
biochemical composition between the bony and cartilaginous regions. The results presented herein highlight
how an optimized mechanochemical microenvironment
can affect the production of tissue-speciﬁc extracellular matrix of the resident cell population seeded in the
various regions of a hydrodynamically loaded osteochondral construct compared to control constructs produced through a noninductive bioprocessing scheme.
Based on our results, we believe that this approach
may have signiﬁcant potential for the production of
the osteochondral unit, as well as other interfacial tissues for use in regenerative capacities. We would be remise, however, if we did not address the dependency
of the ultimate utility of this approach on the further development of enabling material and biofabrication technologies to help achieve cost-effective production and
processing of well-deﬁned robust tissue products. The
promising ﬁndings of the present study represent an important ﬁrst step in the rational design of engineered
osteochondral units through establishment of a platform
for the future optimization of scaffolding formulations
and bioprocessing parameters toward the production
of commercially viable osteochondral tissue products
using microﬂuidic scaffolding strategies.30
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DMEM
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FBS
GAG
GAPDH
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Dulbecco’s modiﬁed Eagle’s medium
dimethyl sulfoxide
fetal bovine serum
glycosaminoglycan
glyceraldehyde-3-phosphate dehydrogenase
mesenchymal stem cell
penicillin–streptomycin–fungizone
quantitative reverse transcription polymerase chain
reaction
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